SCHEMBL9214539

SCHEMBL9214539

O=c1c2ccccc2ccc2ccc(Br)cc12

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2A6 P11509 2/20 0.52
MEN1 O00255 1/20 0.46
KMT2A Q03164 1/20 0.46
RXFP1 Q9HBX9 1/20 0.46
AKR1B1 P15121 2/20 0.45
ALDH1A1 P00352 3/20 0.44
HSD17B10 Q99714 2/20 0.44
TSHR P16473 1/20 0.44
TDP1 Q9NUW8 1/20 0.44
PAX8 Q06710 1/20 0.43
HIF1A Q16665 1/20 0.43
CYP1B1 Q16678 1/20 0.43
MAPK14 Q16539 1/20 0.41
CA1 P00915 1/20 0.41
CA2 P00918 1/20 0.41
HPRT1 P00492 1/20 0.41
POLB P06746 1/20 0.41
HSP90AA1 P07900 1/20 0.40
TLR9 Q9NR96 1/20 0.40
CYP1A2 P05177 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9068487 0.90 CYP2A6 (0.56) CYP2A6MEN1KMT2ARXFP1AKR1B1
SCHEMBL16178092 0.89 HSP90AA1 (0.48) CYP2A6MEN1KMT2AALDH1A1HSD17B10
SCHEMBL19871768 0.85 ERN1 (0.46) CYP2A6MEN1KMT2ARXFP1AKR1B1
SCHEMBL11181615 0.82 ALDH1A1 (0.43) CYP2A6MEN1KMT2ARXFP1AKR1B1
SCHEMBL1527465 0.82 ALDH1A1 (0.64) CYP2A6MEN1KMT2ARXFP1ALDH1A1
SCHEMBL31266523 0.82 ALDH1A1 (0.64) CYP2A6MEN1KMT2ARXFP1ALDH1A1
SCHEMBL268735 0.82 ALDH1A1 (0.65) CYP2A6AKR1B1ALDH1A1HSD17B10TSHR
SCHEMBL29391827 0.82 ALDH1A1 (0.65) CYP2A6AKR1B1ALDH1A1HSD17B10TSHR
SCHEMBL30186719 0.82 ALDH1A1 (0.65) CYP2A6AKR1B1ALDH1A1HSD17B10TSHR
SCHEMBL9765502 0.82 ALDH1A1 (0.52) CYP2A6AKR1B1ALDH1A1HSD17B10TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 55 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10693075-B2 Spiro compound and organic electronic device comprising the same SHANGHAI NICHEM FINE CHEMICAL CO., LTD. (CN) 2020-06-23 US disclosed
US-10693077-B2 Compound and organic electronic device using the same SHANGHAI NICHEM FINE CHEMICAL CO., LTD. (CN) 2020-06-23 US disclosed
US-10693075-B2 Spiro compound and organic electronic device comprising the same SHANGHAI NICHEM FINE CHEMICAL CO., LTD. (CN) 2020-06-23 US disclosed
US-10483468-B2 Compound and organic electronic device using the same SHANGHAI NICHEM FINE CHEMICAL CO., LTD. (CN) 2019-11-19 US disclosed
US-10476006-B2 Compound and organic electronic device using the same SHANGHAI NICHEM FINE CHEMICAL CO., LTD. (CN) 2019-11-12 US disclosed
US-10454039-B2 Compound and organic electronic device using the same SHANGHAI NICHEM FINE CHEMICAL CO., LTD. (CN) 2019-10-22 US disclosed
US-10454039-B2 Compound and organic electronic device using the same SHANGHAI NICHEM FINE CHEMICAL CO., LTD. (CN) 2019-10-22 US disclosed
EP-3281936-B1 COMPOUND AND ORGANIC ELECTRONIC DEVICE USING THE SAME SHANGHAI NICHEM FINE CHEMICAL CO LTD (CN) 2019-10-09 EP disclosed
US-10431751-B2 Compound and organic electronic device comprising the same SHANGHAI NICHEM FINE CHEMICAL CO., LTD. (CN) 2019-10-01 US disclosed
US-10424744-B2 Compound and organic electronic device comprising the same SHANGHAI NICHEM FINE CHEMICAL CO., LTD. (CN) 2019-09-24 US disclosed
EP-0012988-A1 Levorotatory or dextrorotatory enantiomers of 3-halocyproheptadines, process for their preparation and pharmaceutical composition thereof MERCK & CO. INC. (US) 1980-07-09 EP disclosed
US-4132796-A Antipsychotic 3-trifluoromethylsulfinyl analogs of cyproheptadine MERCK & CO., INC. (US) 1979-01-02 US disclosed
US-4104398-A 3-Lower alkoxycyproheptadines as serotonin inhibitors MERCK & CO., INC. (US) 1978-08-01 US disclosed
US-4048223-A 3-Dimethylsulfamoyl-5-[amino(alkyl or alkylidene)]-5H-dibenzo [a,d]cycloheptenes MERCK & CO., INC. (US) 1977-09-13 US disclosed
US-4031222-A ANTIEXTRAPYRAMIDAL, ANTIPSYCHOTIC, ENANTIOMERS, TRANQUILIZERS, ANTICHOLINERGIC MERCK & CO., INC. (US) 1977-06-21 US disclosed
US-4031223-A ANTIEXTRAPYRAMIDAL, ANTIPSYCHOTIC, ENANTIOMERS, TRANQUILIZERS, ANTICHOLINERGIC MERCK & CO., INC. (US) 1977-06-21 US disclosed
US-4020169-A FROM ARYL IODIDE OR BROMIDE AND TRIFLUOROMETHYL THIO COPPER MERCK & CO., INC. (US) 1977-04-26 US disclosed
US-3981917-A Chemical compounds MERCK & CO., INC. (US) 1976-09-21 US disclosed
US-3981877-A APPETITE STIMULANTS MERCK & CO., INC. (US) 1976-09-21 US disclosed
US-3978121-A 5H Dibenzo[a,d]cycloheptene derivatives MERCK & CO., INC. (US) 1976-08-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10424744-B2 Compound and organic electronic device comprising the same CHRM1, CHRM2, ESR1 CYP2A6 518/4885MEN1 305/4885KMT2A 927/4885
US-10693075-B2 Spiro compound and organic electronic device comprising the same ESRRA, REN, ESRRB CYP2A6 632/4885MEN1 2448/4885KMT2A 2239/4885
US-10693077-B2 Compound and organic electronic device using the same SOD1, SCO2, RCOR3 CYP2A6 1142/4885MEN1 2385/4885KMT2A 1209/4885
US-10431751-B2 Compound and organic electronic device comprising the same CHRM1, CHRM2, ESR1 CYP2A6 518/4885MEN1 305/4885KMT2A 927/4885
US-10476006-B2 Compound and organic electronic device using the same ESR1, AOC2, PIEZO1 CYP2A6 112/4885MEN1 205/4885KMT2A 844/4885
US-10454039-B2 Compound and organic electronic device using the same ORC3, AOX1, RCOR3 CYP2A6 497/4885MEN1 2797/4885KMT2A 1422/4885
US-10483468-B2 Compound and organic electronic device using the same ORC3, RBX1, CBX3 CYP2A6 1506/4885MEN1 1725/4885KMT2A 999/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.